+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Coronavirus Disease 2019 (COVID-19) Pandemic Impact on Clinical Trials

  • ID: 5136765
  • Report
  • August 2020
  • Region: Global
  • 52 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 2
Coronavirus Disease 2019 (COVID-19) Pandemic Impact on Clinical Trials

Summary

This PowerPoint based report gives an important expert analysis on how COVID-19 is impacting clinical trials and the potential move toward decentralized clinical trials. Findings are based on a survey conducted with 150 respondents from around the world that belonged to Pharma/Biotech, Government/Academic Institutions, CROs, CMOs, or other contract service providers.

The report includes -
  • Background, Objectives and Designs.
  • Primary Concerns, which include business concerns, clinical trial concerns for decentralized clinical trials and addressing trial disruption.
  • Movement Toward Decentralized Trials, including pre and post pandemic decentralized clinical trials use, future movement toward using decentralized clinical trials and cost comparison.
  • Challenges Facing Decentralized Trials, which explores the biggest challenges and changes that are anticipated for decentralized clinical trials.
Scope
  • A total of 150 the publisher's Pharma clients and prospects from the around the world participated in the seven-minute survey, which was fielded from June 4, 2020 to June 22, 2020.
  • This report includes and is based around industry opinions on COVID-19’s impact on clinical trials and the use of decentralized clinical trials.
Reasons to Buy
  • Understand companies’ primary concerns about the COVID-19 pandemic.
  • Determine the impact of COVID-19 to date on clinical trials.
  • Assess companies’ future plans to use decentralized clinical trials.
  • Track changes to clinical trial strategy and attitudes.
Note: Product cover images may vary from those shown
2 of 2
1 Study Design
1.1 Background
1.2 Objectives and Design

2 Primary Business and Clinical Trial Concerns
2.1 Primary Business Concerns
2.2 Primary Clinical Trial Concerns
2.3 Addressing Clinical Trial Disruptions

3 Movement Toward Decentralized Trials
3.1 Pre-pandemic Decentralized Trials Use
3.2 Post-pandemic Decentralized Trials Use
3.3 Future Movement Toward Decentralized Clinical Trial Use
3.4 Cost Comparison

4 Challenges Facing Decentralized Trials
4.1 Biggest Challenges
4.2 Biggest Changes

5 Summary

6 Appendix
Note: Product cover images may vary from those shown
Adroll
adroll